Isolation and Validation of the First Functional HLA-a*01:01 Restricted EBV-LMP2 Specific T Cells for Treatment of EBV Associated Type II/III Lymphomas

Author(s):: Huisman, W.; Maarel, L.E. van der; Hageman, L.; Jong, R.C.M. de; Amsen, D.; Falkenburg, J.H.F.; Jedema, I.

Published: 2018
Publication type: Other

Date issued: 2018-11-29
Language: English
Publisher: AMER SOC HEMATOLOGY
hdl: 1887/122088
doi: 10.1182/blood-2018-99-127